http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_edd1daf505134848c30ef4d1839ab651
Outgoing Links
Predicate | Object |
---|---|
family-name | Navarro |
name | Matilde Navarro |
given-name | Matilde |
organization-name | 3Institut Catala d'Oncologia, Hospitalet, Barcelona, Spain; and Servicio de Prevención y Control del Cáncer, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, España. [email protected] Department of Internal Medicine, Granollers Hospital, Barcelona Hereditary Cancer Program, Catalan Institute of Oncology IDIBELL‐IGTP‐IDIBGI Badalona Spain; Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL Barcelona Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain Oncology Section, Group of Physiology of Cellular Nucleus, Faculty of Medicine, Barcelona, Spain From the Hôpital Pitié-Salpêtrière; Université Paris 06; Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR) Oncology Multidisciplinary Group; Hôpital Saint-Antoine and L'Institut National de la Santé et de la Recherche Médicale, Paris, France; Arcispedale Santa Maria Nuova, Reggio Emilia; Ospedale Mater Salutis, Legnago, Italy; Institut Català d'Oncologia, l'Hospitalet de Llobregat, Llobregat; Valle d'Hebron University Hospital, Barcelona; Hospital Marqués de Valdecilla, Santander, Spain; Dorset... Hereditary Cancer Program, Catalan Institute of Oncology, Institut d’Investigació Biomédica de Bellvitge (IDIBELL), ONCOBELL Program, Hospitalet de Llobregat, Barcelona, Spain; Hereditary Cancer Program, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL Hospitalet de Llobregat Barcelona Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain Catalan Institute of Oncology, Barcelona, Catalonia, Spain Programa de Cáncer Hereditario, Unidad de Consejo Genético, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, España. [email protected] Hereditary Cancer Program; Catalan Institute of Oncology; IDIBELL; Hospitalet de Llobregat; Barcelona Spain; Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell); IDIBELL; Hospitalet de Llobregat; Barcelona Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC); Madrid Spain Renal Physiology Section, Nephrology Service, Hospital Italiano de Buenos Aires, Peron 4190, 1181 ACH Buenos Aires, Argentina Cancer Prevention and Control Department, Catalan Institute of Oncology, Barcelona, Spain 1Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Spain. Department of Radiotherapy and Oncology, Valle Hebron Hospital, Barcelona, Spain From the Laboratory of Translational Research and Departments of Medical Oncology and Cancer Epidemiology, Institut Català d'Oncologia-Institut d’Investigació de Bellvitge (IDIBELL); Department of Pathology and Department of Surgery, Hospital Universitario de Bellvitge-IDIBELL; Department of Molecular Oncology, Institut de Recerca Oncològica-IDIBELL, L'Hospitalet de Llobregat; Department of Pathology, Hospital Vall d'Hebron; and Laboratori de Bioestadística I Epidemiologia, Facultat de Medicina,... Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL Hospitalet de Llobregat Barcelona Spain; Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL Hospitalet de Llobregat Barcelona Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Spain Hereditary Cancer Program, ONCOBELL‐IDIBELL‐IDIBGI‐IGTP, Catalan Institute of OncologyCIBERONC Barcelona Spain Hereditary Cancer Program Catalan Institute of Oncology, IDIBELL, CIBERONC, Hospitalet de Llobregat Spain; Hereditary Cancer Program Catalan Institute of Oncology, Hospital Germans Trias i Pujol Badalona Spain Hereditary Cancer Program; Catalan Institute of Oncology, IDIBELL; Hospitalet de Llobregat; Spain |
Incoming Links
Showing number of triples: 1 to 116 of 116.